The study also found lengthy eye examination and eyewear purchase cycles, with averages of 21 and 24 months respectively.

EyeCon 2024 will be running from September 27-28 in Fort Lauderdale, Florida.

The study, conducted in July 2024, reported decreases in all areas of practice performance, including revenue, staff retention, and patient acquisition and retention.

The Finnish company's new device sports a universal adapter and rebound tonometry technology.

The FDA and Palatin agreed on a clear regulatory path for PL9643 NDA submission in DED. The company hopes to start patient enrollment to start in the fourth quarter of calendar year 2024.

Las Vegas, Nevada is where the latest in eyewear and fashion will meet a focus on education.

By identifying progressive GA earlier, primary eye care providers can make timely referrals and save patients’ visual function.

The National High Traffic Safety Administration states that “nighttime driving is inherently challenging due to decreased visibility."

Catch up on what happened in optometry during the week of September 2-September 6.

Resources available during the month include a seminar series and course bundles.

Young will be aiding in expanding real-world evidence programs to promotion the adoption of Brightstar’s BrightMEM corneal allograft for the treatment of limbal stem cell deficiency and persistent epithelial defects.

Medical experts discuss the need for early intervention in corneal conditions.

After a brief introduction, medical experts discuss differential diagnosis for common corneal conditions.

Living a long life and preserving eye health can go hand in hand.

Top-line data from the trial evaluating phentolamine ophthalmic solution 0.75% for the treatment of presbyopia are expected in 2025.

This year's theme, "Love Your Eyes," focuses on children's vision and eye health.